Isoxsuprine%2520hydrochloride

# Isoxsuprine hydrochloride ## Overview Isoxsuprine is a beta-adrenergic receptor agonist with vasodilatory and uterine relaxant properties. Its use has declined significantly due to limited efficacy evidence and availability of safer alternatives. ## Primary Indications - **Peripheral vascular disease** (e.g., intermittent claudication) – historical use; not first-line. - **Cerebral vascular insufficiency** – historical use; not recommended. - **Premature labor (tocolysis)** – off-label; not recommended due to poor efficacy and maternal-fetal safety concerns. ## Adult Dosing - **Peripheral vascular disease**: 10–20 mg orally 3–4 times daily. - **Maximum oral dose**: 80 mg/day. - **IM/IV use** (rare, hospital setting only): 5–10 mg 2–3 times daily. IV administration requires careful hemodynamic monitoring. ## Pediatric Dosing - **Not established** for any indication. Use is not recommended in children. ## Dose Adjustments - **Renal impairment**: No specific guidelines; use caution. - **Hepatic impairment**: No specific guidelines; use caution. - **Elderly**: Start at lower end of dosing range due to increased sensitivity to hypotension. ## Contraindications - **Hypersensitivity** to isoxsuprine or any component. - **Recent arterial hemorrhage** or bleeding disorders. - **Severe hypotension** or shock. - **Immediately postpartum** (risk of uterine atony and hemorrhage). - **Concurrent use with other vasodilators** (additive hypotension risk). ## Adverse Effects - **Common**: Hypotension, dizziness, flushing, palpitations, tachycardia, nausea, vomiting. - **Serious**: Severe hypotension, cardiac arrhythmias, pulmonary edema (especially with tocolytic use), fetal/neonatal adverse effects (hypoglycemia, hypotension, ileus) when used in pregnancy. ## Key Drug Interactions - **Antihypertensives**: Additive hypotensive effect. - **Beta-blockers**: May blunt therapeutic response; risk of paradoxical hypertension. - **General anesthetics**: Enhanced hypotensive effect. - **Oxytocic drugs**: Antagonism of uterine contraction (postpartum risk). ## Monitoring - **Blood pressure and heart rate** – especially during IV use or dose titration. - **Signs of hypotension** (dizziness, syncope). - **Fetal heart rate and uterine activity** if used in pregnancy (not recommended). ## Clinical Pearls - **Efficacy is poorly supported** by modern evidence; isoxsuprine is rarely used in current practice. - **Not recommended for tocolysis** – safer, more effective alternatives exist (e.g., nifedipine, terbutaline). - **Availability may be limited**; many regions have discontinued the product. - **Dosing protocols vary by institution** – always follow local guidelines if used. --- *This information is for educational purposes only. Always verify current prescribing information from a reliable drug reference and consult local protocols before initiating therapy.*